Zasocitinib
Zasocitinib is a pharmaceutical drug with 10 clinical trials. Currently 6 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
6
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Clinical Trials (10)
A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10